Tharimmune, Inc. (CNTN)

AI-Powered SEC Filing Analysis

Current Report Filed: 2026-03-31

Key Insights

Tharimmune, Inc. (CNTN) reported full year 2025 results, indicating the company's performance during the year.
The filing does not provide any details on the company's financial or operational performance, limiting the insights that can be drawn.
Without more information on the company's results, it is difficult to assess the significance of this filing for investors.

Annual Report Filed: 2026-03-31

Key Insights

Tharimmune, Inc. (CNTN) appears to be actively raising capital through various financing arrangements, including a private placement, PIPE offerings, and a direct public offering in 2025.
The company has entered into an At-The-Market (ATM) agreement, which provides additional flexibility to raise funds as needed.
Tharimmune has issued a significant number of warrants and options, which could lead to future dilution for shareholders if exercised.

Get real-time filing analysis in the app

Download on the App Store

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.